Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Roy Pattipeiluhu, Stefan Crielaard, Iris Klein-Schiphorst, Bogdan I. Florea, Alexander Kros, Frederick Campbell
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Nanoparticle-Blood Interactions: The Implications on Solid Tumour Targeting
10.1039/c4cc07644c · 2015
The Crown and the Scepter: Roles of the Protein Corona in Nanomedicine
10.1002/adma.201805740 · 2019
Protein Corona: A New Approach for Nanomedicine Design
10.2147/ijn.s129300 · 2017
Understanding and Controlling the Interaction of Nanomaterials with Proteins in a Physiological Environment
10.1039/c1cs15233e · 2012
Understanding Biophysicochemical Interactions at the Nano-Bio Interface
10.1038/nmat2442 · 2009
Mechanistic Understanding of in Vivo Protein Corona Formation on Polymeric Nanoparticles and Impact on Pharmacokinetics
10.1038/s41467-017-00600-w · 2017
Cloaking Nanoparticles with Protein Corona Shield for Targeted Drug Delivery
10.1038/s41467-018-06979-4 · 2018
Transferrin-Functionalized Nanoparticles Lose Their Targeting Capabilities When a Biomolecule Corona Adsorbs on the Surface
10.1038/nnano.2012.237 · 2013
In Vivo Formation of Protein Corona on Gold Nanoparticles. The Effect of Their Size and Shape
10.1039/c7nr08322j · 2018
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
Unveiling the in Vivo Protein Corona of Circulating Leukocyte-like Carriers
10.1021/acsnano.7b00376 · 2017
Anti-Polyethylene Glycol Antibodies Alter the Protein Corona Deposited on Nanoparticles and the Physiological Pathways Regulating Their Fate in Vivo
10.1016/j.jconrel.2018.08.022 · 2018
In Vivo Protein Corona Patterns of Lipid Nanoparticles
10.1039/c6ra25493d · 2017
Nanoparticle–Proteome in Vitro and in Vivo
10.1039/c8tb01634h · 2018
Time Evolution of the Nanoparticle Protein Corona
10.1021/nn901372t · 2010
Time Evolution of Nanoparticle-Protein Corona in Human Plasma: Relevance for Targeted Drug Delivery
10.1021/la401192x · 2013
Time-Evolution of in Vivo Protein Corona onto Blood-Circulating PEGylated Liposomal Doxorubicin (DOXIL) Nanoparticles
10.1039/c5nr09158f · 2016
Understanding the Nanoparticle-Protein Corona Using Methods to Quantify Exchange Rates and Affinities of Proteins for Nanoparticles
10.1073/pnas.0608582104 · 2007
The Nanoparticle Biomolecule Corona: Lessons Learned – Challenge Accepted?
10.1039/c5cs00217f · 2015
Techniques for the Experimental Investigation of the Protein Corona
10.1016/j.copbio.2017.02.009 · 2017
Possibilities and Limitations of Different Separation Techniques for the Analysis of the Protein Corona
10.1002/anie.201902323 · 2019
The Nanoparticle Protein Corona Formed in Human Blood or Human Blood Fractions
10.1371/journal.pone.0175871 · 2017
Nanoparticle Interaction with Plasma Proteins as It Relates to Particle Biodistribution, Biocompatibility and Therapeutic Efficacy
10.1016/j.addr.2009.03.009 · 2009
Nanoparticle Size and Surface Properties Determine the Protein Corona with Possible Implications for Biological Impacts
10.1073/pnas.0805135105 · 2008
The Biomolecular Corona of Nanoparticles in Circulating Biological Media
10.1039/c5nr03701h · 2015
In Vivo Biomolecule Corona around Blood-Circulating, Clinically Used and Antibody-Targeted Lipid Bilayer Nanoscale Vesicles
10.1021/acsnano.5b03300 · 2015
Photocrosslinking and Click Chemistry Enable the Specific Detection of Proteins Interacting with Phospholipids at the Membrane Interface
10.1016/j.chembiol.2008.11.009 · 2009
Photo-Affinity Labeling (PAL) in Chemical Proteomics: A Handy Tool to Investigate Protein-Protein Interactions (PPIs)
10.1186/s12953-017-0123-3 · 2016
Selective Photoaffinity Probe That Enables Assessment of Cannabinoid CB2 Receptor Expression and Ligand Engagement in Human Cells
10.1021/jacs.7b11281 · 2018
Liposomal Drug Delivery Systems: From Concept to Clinical Applications
10.1016/j.addr.2012.09.037 · 2013
Liposomal Formulations in Clinical Use: An Updated Review
10.3390/pharmaceutics9020012 · 2017
Directing Nanoparticle Biodistribution through Evasion and Exploitation of Stab2-Dependent Nanoparticle Uptake
10.1021/acsnano.7b06995 · 2018
Rapid Formation of Plasma Protein Corona Critically Affects Nanoparticle Pathophysiology
10.1038/nnano.2013.181 · 2013
Analysis of Plasma Protein Adsorption onto DC-Chol-DOPE Cationic Liposomes by HPLC-CHIP Coupled to a Q-TOF Mass Spectrometer
10.1007/s00216-010-4104-y · 2010
Clinically-Proven Liposome-Based Drug Delivery: Formulation, Characterization and Therapeutic Efficacy
10.4172/scientificreports.195 · 2012
Adhesion Forces of Lipids in a Phospholipid Membrane Studied by Molecular Dynamics Simulations
10.1016/s0006-3495(98)74016-0 · 1998
A Suite of “Minimalist” Photo-Crosslinkers for Live-Cell Imaging and Chemical Proteomics: Case Study with BRD4 Inhibitors
10.1002/anie.201706076 · 2017
A Comparative Study of Bioorthogonal Reactions with Azides
10.1021/cb6003228 · 2006
Myocet (Liposome-Encapsulated Doxorubicin Citrate): A New Approach in Breast Cancer Therapy
10.1517/14656566.3.12.1739 · 2002
Liposomal Amphotericin B as Initial Therapy for Invasive Mold Infection: A Randomized Trial Comparing a High – Loading Dose Regimen with Standard Dosing (AmBiLoad Trial)
10.1086/514341 · 2007
Neovascular Targeting Therapy: Paclitaxel Encapsulated in Cationic Liposomes Improves Antitumoral Efficacy
2003
The Proteomics Identifications (PRIDE) Database and Associated Tools: Status in 2013
10.1093/nar/gks1262 · doi-reference
In Situ Analysis of Liposome Hard and Soft Protein Corona Structure and Composition in a Single Label-Free Workflow
10.1039/c9nr08186k · doi-reference
Preservation of the Soft Protein Corona in Distinct Flow Allows Identification of Weakly Bound Proteins
10.1016/j.actbio.2018.05.057 · doi-reference
Supervised Learning and Mass Spectrometry Predicts the in Vivo Fate of Nanomaterials
10.1021/acsnano.9b02774 · doi-reference
Topology of Human Apolipoprotein E3 Uniquely Regulates Its Diverse Biological Functions
10.1073/pnas.1106420108 · doi-reference
Interaction of the N-Terminal Domain of Apolipoprotein E4 with Heparin
10.1021/bi002417n · doi-reference
Characterization of the Heparin Binding Sites in Human Apolipoprotein E
10.1074/jbc.m213207200 · doi-reference
Plasma Lipoproteins: Apolipoprotein Structure and Function
10.1016/s0022-2275(20)34443-6 · doi-reference
Biomolecular Coronas Provide the Biological Identity of Nanosized Materials
10.1038/nnano.2012.207 · doi-reference
In-Gel Digestion for Mass Spectrometric Characterization of Proteins and Proteomes
10.1038/nprot.2006.468 · doi-reference
Illustrate: Software for Biomolecular Illustration
10.1016/j.str.2019.08.011 · doi-reference
Comparison of Label-Free Methods for Quantifying Human Proteins by Shotgun Proteomics
10.1074/mcp.m500084-mcp200 · doi-reference
Drift Time-Specific Collision Energies Enable Deep-Coverage Data-Independent Acquisition Proteomics
10.1038/nmeth.2767 · doi-reference
Absolute Quantification of Proteins by LCMS E
10.1074/mcp.m500230-mcp200 · doi-reference
Quantitative Profiling of the Protein Coronas That Form around Nanoparticles
10.1038/nprot.2014.139 · doi-reference
Assessment of Label-Free Quantification in Discovery Proteomics and Impact of Technological Factors and Natural Variability of Protein Abundance
10.1021/acs.jproteome.6b00645 · doi-reference
Practical Considerations, Challenges, and Limitations of Bioconjugation via Azide-Alkyne Cycloaddition
10.1021/acs.bioconjchem.7b00633 · doi-reference
Comparative Analysis of Click Chemistry Mediated Activity-Based Protein Profiling in Cell Lysates
10.3390/molecules181012599 · doi-reference